NC-LENOVO
Lenovo (HKSE: 992) (ADR: LNVGY), the global technology powerhouse, is offering Lenovo Hybrid Cloud Advisory Services to help enterprises simplify the complexity of hybrid cloud design and create implementation-ready, future-proofed plans in as few as six weeks. Lenovo leverages four decades of experience helping global CIOs ease cloud and hybrid cloud challenges, including demands associated with emerging AI-related workloads. With the new services, Lenovo expert consultants guide enterprises through hybrid cloud needs, accelerating time to value, improving cost efficiency, and building flexibly scalable foundations.
The new era of AI is hybrid, and today’s IT organizations are converting their raw data into actionable insights with hybrid cloud solutions that are capable of harnessing data, no matter where it lives. Lenovo hybrid cloud solutions boost AI performance and agility by delivering more compute and faster memory when and where it’s needed, offering a full-stack portfolio and purpose-built solutions that are specific to each customer and use case. To support AI optimization, Lenovo Hybrid Cloud Advisory Services help design a cloud approach customized for today, and ready to flexibly scale and adapt to future needs.
“At a time when the need for modern infrastructure and solutions has never been greater, IT is challenged to evolve cloud implementations. This is evident in our most recent Lenovo global CIO report in which 82% of respondents marked cloud transformation as challenging,” said Dale Aultman, Vice President & General Manager, Hybrid Cloud Services at Lenovo Group. “We introduced Lenovo Hybrid Cloud Advisory Services to simplify cloud design strategies and pave the way for AI implementations. We bring a global team of trusted experts to help our customers develop future-proofed, tailor-made solutions to rapidly modernize hybrid clouds and ultimately deliver better business outcomes.”
Many organizations need to modernize or update their hybrid clouds due to changing business needs, spiraling costs, or performance issues. In fact, Lenovo’s third annual global CIO report found that 29% of respondents still find cloud transformation a top priority, behind AI implementation, cybersecurity, and data privacy. Demand for data center capacity continues to grow and, with increasing interest in AI, is also accelerating. IT leaders are concerned about meeting this demand due to challenges around qualified staff, procuring equipment, forecasting future requirements and energy efficiencies. Changing licensing models are also generating disruption and requiring IT leaders to lean on partners.
“Successful hybrid cloud strategy and design is imperative for enterprises, yet the underlying complexity involved cannot be understated,” said Steven Dickens, Futurum Group. “According to our research, hybrid is 2x the size of public cloud when it comes to deployment modalities for AI, therefore the need for flexibility and futureproofing becomes critical. Partnering with experts, such as Lenovo, will be the smart path forward for many enterprises.”
Lenovo Hybrid Cloud Advisory Services offers customized, strategic expertise, and a trusted partner to manage the complexity of hybrid cloud design. Lenovo experts help turn hybrid cloud vision into reality with better outcomes using customer assessment, proven methodologies, and strategic advice and approach recommendation. Lenovo’s tech-agnostic expertise, deep industry alliances and partnerships, pre-validated solutions, and experience in every aspect of hybrid cloud creation provide clear value while helping future-proof an organization’s hybrid cloud. Customer benefits include:
- Speed/Time to value
- Holistic: Cloud/software/infrastructure expertise from single provider
- End-to-end expertise
- Engineering quality
- Global presence
Lenovo Hybrid Cloud Advisory Services features a breadth of offerings that are now available, expanding Lenovo’s advisory services capabilities and complementing Lenovo’s AI services portfolio. Channel availability will launch in September 2024.
For more information regarding Lenovo Hybrid Cloud Advisory Services visit here.
About Lenovo
Lenovo is a US$57 billion revenue global technology powerhouse, ranked #248 in the Fortune Global 500, and serving millions of customers every day in 180 markets. Focused on a bold vision to deliver Smarter Technology for All, Lenovo has built on its success as the world’s largest PC company with a full-stack portfolio of AI-enabled, AI-ready, and AI-optimized devices (PCs, workstations, smartphones, tablets), infrastructure (data center, storage, edge, high performance computing and software defined infrastructure), software, solutions, and services. Lenovo’s continued investment in world-changing innovation is building a more equitable, trustworthy, and smarter future for everyone, everywhere. Lenovo is listed on the Hong Kong stock exchange under Lenovo Group Limited (HKSE: 992) (ADR: LNVGY). To find out more visit https://www.lenovo.com, and read about the latest news via our StoryHub.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240828812342/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67th American Society of Hematology (ASH) Annual Meeting6.12.2025 15:30:00 CET | Press release
Results from Phase 2a IMPRSSION study demonstrate sapablursen significantly reduced phlebotomy rate, controlled hematocrit and increased serum hepcidin Sapablursen was generally safe and well tolerated Results support further development of sapablursen in a Phase 3 study Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the oral presentation of positive results from the Phase 2a IMPRSSION study of sapablursen in patients with polycythemia vera (PV) at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, FL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251206361611/en/ The results were presented by Ionis Pharmaceuticals, who discovered and developed sapablursen and conducted the IMPRSSION study. In March 2025, Ionis and Ono entered into a license agreement in which On
Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera6.12.2025 15:30:00 CET | Press release
52-Week Results from the Phase 3 VERIFY Study of Rusfertide Demonstrated Sustained Hematocrit Control and Response, Defined by Absence of Phlebotomy Eligibility, with No New Safety SignalsThese Data Build on Positive 32-Week Primary Analysis from VERIFY, Which Met its Primary Efficacy Endpoint and All Four Key Secondary EndpointsPatients Crossing Over from Placebo to Rusfertide at 32 Weeks Achieved a Similar Response Rate to Those Initially Randomized to Rusfertide, with 77.9% Achieving Absence of Phlebotomy Eligibility Between Weeks 40-52Four-Year Results from the Combined REVIVE and Long-Term Extension THRIVE Study Demonstrated a 13-Fold Reduction in Annual Rate of Phlebotomies from Baseline Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX) and Takeda (TSE:4502/NYSE:TAK) announce that new 52-week results from the pivotal Phase 3 VERIFY study evaluating rusfertide in patients with polycythemia vera (PV) will be presented in an oral presentation at the 67th American Society
Vertex Presents New Data on CASGEVY®, Including First-Ever Data in Children Ages 5-11 Years, at the American Society of Hematology Annual Meeting and Announces Plan for Global Regulatory Submissions6.12.2025 13:01:00 CET | Press release
- Data from pivotal studies of CASGEVY in children ages 5-11 years with severe sickle cell disease or transfusion-dependent beta thalassemia demonstrates the transformative potential of the therapy in younger patients -- Efficacy and safety data in children 5-11 years are consistent with the durable and positive benefit/risk profile established from clinical studies in patients 12 years of age and older -- Vertex expects to initiate global regulatory submissions for CASGEVY in children 5-11 years in 1H 2026 - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data from multiple studies demonstrating the clinical benefits of CASGEVY® (exagamglogene autotemcel) in people ages 5 years and older living with severe sickle cell disease (SCD) or transfusion-dependent beta thalassemia (TDT). The results, including the first presentation of clinical data from pivotal studies in children ages 5-11 years, and longer-term data from the pivotal studies of people with severe SCD and
Leading Global Scientists Gather at Tengchong Scientists Forum to Explore Innovative Pathways in Frontier Technologies6.12.2025 12:31:00 CET | Press release
The 2025 Tengchong Scientists Forum opened on Saturday in southwest China’s Yunnan Province, convening leading scientists and academic figures to examine innovation across frontier fields including artificial intelligence, biodiversity and quantum technology. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251205499197/en/ Opening ceremony of Tengchong Scientists Forum on 6th December, 2025 Notable participants include Nobel Physics laureate Konstantin Novoselov, Fields Medalist Efim Zelmanov and Turing Award winner Andrew Chi-Chih Yao, who join 127 academicians, 77 university presidents from China and abroad, over 400 scholars and more than 600 entrepreneurs and financiers. The gathering aims to deepen collaboration between cutting-edge research and industrial development. Under the theme “Science · AI changing the World,” the forum features ten sub-forums, academic sessions and thematic events supporting major cooperation p
Lattice Wins 2025 Global Semiconductor Alliance Award6.12.2025 00:49:00 CET | Press release
‒ Named Most Respected Public Semiconductor Company Achieving $100 Million to $500 Million in Annual Sales ‒ Lattice Semiconductor (NASDAQ: LSCC), the low power programmable leader, today announced that it was selected as ‘Most Respected Public Semiconductor Company’ at the 2025 Global Semiconductor Alliance (GSA) Awards. The GSA awards recognize companies that have demonstrated excellence through their success, vision, strategy, and future opportunities in the industry as determined by votes from GSA members. “We are honored to be recognized by the Global Semiconductor Alliance and our peers as one of 2025’s most respected public semiconductor companies. This recognition reflects the dedication of the Lattice team and the trust of our customers, partners, suppliers, and investors. Looking ahead, we remain laser-focused on driving innovation and strengthening our role as the trusted low power programmable leader for semiconductor and system solutions,” said Ford Tamer, Chief Executive
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom